Scripps Clinic Specialist Discusses Future of Allergy Treatments

Developing treatments for infants and young children remains challenging

Allergy PR. Scripps Health, San Diego.

John Kelso, MD, allergist at Scripps Clinic, was part of a Food and Drug Administration panel to discuss the development and approval of immunotherapies for curing allergic conditions. In an interview with MedPage Today, Dr. Kelso discussed the need to consistently reproduce study conditions and the challenges with developing treatments for infants and young children.

Read the article FDA Mulls Parameters for Allergy Therapies

Media Contact

Kristin Reinhardt

Related tags: